Keros Therapeutics KROS
NASDAQ KROS
$11.35 +0.17 (+1.52%)
At close: Oct 22, 2026 · 4:00 PM EDT

Keros Therapeutics (KROS) Non Operating Interest Expenses (2019 - 2022)

Updated

Keros Therapeutics (KROS) recorded Non Operating Interest Expenses of $1,000 in FY2022, down 75.0% from $4,000 in FY2021.

Analysis

Keros Therapeutics (KROS) Non Operating Interest Expenses (2019 - 2022) Analysis & Trends

  • Per Business Quant data, KROS's Non Operating Interest Expenses was $4,000 in FY2021 (-33.3%) and $6,000 in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn -
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn 217.00 Mn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn -
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn -
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn 462.00 Mn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn 435.00 Mn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn 673.00 Mn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn 247.00 Mn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn -
10 Keros Therapeutics 225.04 Mn -1.70 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2022 1,000.00
Dec 31, 2021 1,000.00
Sep 30, 2021 1,000.00
Jun 30, 2021 1,000.00
Mar 31, 2021 1,000.00
Dec 31, 2020 1,000.00
Sep 30, 2020 2,000.00
Jun 30, 2020 1,000.00
Mar 31, 2020 2,000.00
Sep 30, 2019 3,000.00
Jun 30, 2019 2,000.00
Mar 31, 2019 2,000.00
API Access

Keros Therapeutics Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=KROS&period=max&api_key=YOUR_API_KEY